Press Realeases

For Media Inquiries:

Contact Julie Livingston julie@medshadow.org | 347-239-0249

Suzanne Robotti, President, MedShadow Foundation, Named to FDA Drug Safety and Risk Management Advisory Committee

February 14, 2017, New York, NY – The Food and Drug Administration (FDA) has named Suzanne Robotti, founder and president of MedShadow Foundation, to its Drug Safety and Risk Management Advisory Committee as the Consumer Representative. Next month, she will attend her first hearing where a prescription opioid drug will Continue Reading →

MedShadow Receives Spring 2016 Digital Health Award for Its Website

June 13, 2016, New York, NY – MedShadow has been recognized with a Spring 2016 Digital Health Awards Silver designation for its website in the Nonprofit category. Winners were announced on June 10th.  Formerly known as the Web Health Awards, the Digital Health Awards are held twice each year – Continue Reading →

Prince’s Fentanyl Overdose & Public Misconceptions About Opioids

“There’s a straight line between the overprescribing of opioids, the public’s misconceptions about these drugs and the rapidly rising number of accidental deaths from opioid addiction.”

MedShadow Foundation Welcomes New Content Editor, Jonathan Block

Online health advocacy source broadens coverage of side effects, risks and benefits of medicine

NEW YORK, NY, April 28th, 2016 – MedShadow Foundation, an online nonprofit that educates consumers on the side effects, risks and benefits of medicine, has announced the appointment of Jonathan Block as Content Editor.

“We Continue Reading →

MedShadow Wins 2 AVA Digital Awards

The AVA Digital Awards today announced winners for the 2016 international awards competition. MedShadow Foundation received two gold awards in the nonprofit website and nonprofit video for the web categories.

MedShadow is Honored with 2015 Digital Health Award for Website/Content

MedShadow has received a 2015 Digital Health Awards Bronze in the Web-based Digital Health category.

MedShadow Foundation Offers Viewpoint on Study Linking Pregnant Women’s Use of SSRIs & Autism

Side effects-focused health advocacy group questions efficacy of research study

December 15, 2015, New York, NY – On December 14th, JAMA Pediatrics published a report on a University of Montreal study that makes a clear correlation between the use of SSRIs (selective serotonin reuptake inhibitors) — a common group Continue Reading →

 

 

About MedShadow Foundation

Founded in 2012 by Suzanne Robotti, MedShadow Foundation seeks to empower patients and encourage discussion between patient and health care provider about the short and long term side effects of prescription medication. MedShadow Foundation uses its website and various social media platforms to gather and report breaking news and resources related to the side effects of prescription medications. While recognizing the beneficial, often life-saving effects of prescription drugs, we know that accurate and complete information on side effects is frequently lacking.